X4 PHARMACEUTICALS, INC (XFOR) Operating margin 2020–2025
X4 PHARMACEUTICALS, INC (XFOR) operating margin by fiscal year — reported operating income divided by reported revenue.
-247.4%FY2025 · since FY2020: -1995.8% → -247.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -247.4% | +1176.1 pp |
| FY2024 | -1423.6% | — |
| FY2020 | -1995.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross profitXFOR Gross marginXFOR Operating incomeXFOR Operating cash flowXFOR Free cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Total liabilitiesXFOR Shareholders’ equityXFOR overview →